Ákos I.
- Country
- Hungary
- Department
- Department of Internal Medicine and Oncology
Research Overview
- Long-term Safety, Tolerability, and Efficacy of Balinatunfib in Adults with Crohn's Disease or Ulcerative Colitis: A Multicenter Extension Study
- A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 3 Active Dose Regimens of MORF-057 in Adults with Moderately to Severely Active Ulcerative Colitis (EMERALD-2)
- Phase 3b, Randomized, Open‑Label, Active‑Controlled Trial Comparing Guselkumab Versus Risankizumab for Efficacy and Safety in Moderately to Severely Active Crohn’s Disease
Data & Insights
Has run more than one trial at 334 of 538 partner sites.
Specializations
Cardiovascular medicine
Ákos Iliás is involved in clinical research on atherosclerotic cardiovascular disease, heart failure, acute myocardial infarction, atrial fibrillation, and ischemic stroke, with attention to risk reduction, lipid disorders, and thromboembolic prevention.
- Coronary artery disease
- Heart failure with preserved ejection fraction
- Elevated lipoprotein(a)
- Venous thromboembolism
His trial activity also extends to hypertrophic cardiomyopathy, hypercholesterolemia, and broader cardiometabolic prevention.
Gastroenterology and inflammatory bowel disease
His research landscape includes Crohn’s disease, ulcerative colitis, and related inflammatory disorders of the digestive tract, reflecting a strong therapeutic focus on chronic immune-mediated gastrointestinal disease.
- Moderate-to-severe Crohn’s disease
- Moderate-to-severe ulcerative colitis
- Short bowel syndrome
- Clostridioides difficile infection
He is also involved in studies addressing fistulizing perianal Crohn’s disease and other refractory intestinal inflammatory conditions.
Oncology and hematologic malignancies
Ákos Iliás participates in trials across lung cancer, prostate cancer, bladder cancer, and multiple hematologic malignancies, including plasma-cell and B-cell disorders.
- Non-small cell lung cancer
- Multiple myeloma
- Diffuse large B-cell lymphoma
- Acute myeloid leukemia
His portfolio also includes metastatic solid tumors, urothelial carcinoma, and head and neck squamous cell carcinoma.
Autoimmune and immune-mediated disease
His clinical trial involvement covers a wide range of autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, psoriatic arthritis, and bullous pemphigoid.
- Myasthenia gravis
- Sjögren’s disease
- Systemic sclerosis
- Immune thrombocytopenia
He is also active in research on vasculitis, inflammatory myopathies, and other immune-mediated systemic disorders.
Neurology, ophthalmology, and metabolic disease
His research interests further extend to migraine, epilepsy, Alzheimer’s disease, and diabetic retinopathy, alongside metabolic conditions such as obesity and type 2 diabetes.
- Age-related macular degeneration
- Diabetic macular edema
- Multiple sclerosis
- Metabolic dysfunction-associated steatohepatitis
These studies indicate involvement in both chronic neurological care and vision-threatening retinal disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.